Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00336076 · ClinicalTrials.gov registry record
Molecular Mechanisms and Diagnosis of Mastocytosis
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 136
- Enrollment target
NCT00336076: Completed study, sponsored by University of Michigan.
NCT00336076 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00336076 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
Mastocytosis is a disorder characterized by presence of excessive numbers of mast cells in skin, bone marrow and internal organs. It can affect both children and adults, males and females and individuals from all ethnic backgrounds, although precise demographic information about the affected populations is not available as it is a rare disorder. Mastocytosis in children is generally limited to the skin and follows a self limited course, while it is a disorder of the hematopoietic stem cell associated with somatic mutations of the c-kit gene in most patients with adult-onset of disease. There is no known curative therapy for most patients with systemic mastocytosis. Recent research studies identified several subtypes of disease with distinct clinical and pathologic features, however, a precise understanding of the incidence as well as molecular pathology of different disease subtypes is lacking. This study aims to examine molecular and cellular pathological aspects of disease in patients with mastocytosis and correlate findings with clinical presentation and prognosis. Patients will undergo a routine history and physical examination, and diagnostic tests will be ordered as dictated by each patient's clinical presentation. Blood and bone marrow will be obtained for diagnostic and research purposes. Genetic analysis of the c-kit gene regulating mast cell growth and differentiation will be performed. It is hoped that findings obtained from this study will help to design novel therapies for mastocytosis and other disorders in which mast cells play a critical role.
Primary Outcome
Patients were categorized into one of the clonal and non-clonal mast cell disorder categories after availability of diagnostic data
Interventions
- OTHER Collection of blood and bone marrow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-07 |
What the finished NCT00336076 record still lists
NCT00336076 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Collection of blood and bone marrow is the first listed.
NCT00336076 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00336076 about?
NCT00336076 is a clinical study titled "Molecular Mechanisms and Diagnosis of Mastocytosis". Mastocytosis is a disorder characterized by presence of excessive numbers of mast cells in skin, bone marrow and internal organs. It can affect both children and adults, males and females and individuals from all ethnic backgrounds, although precise demographic information about the affected populat...
What is the current status of trial NCT00336076?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2004-07. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00336076?
The interventions under investigation include: Collection of blood and bone marrow (OTHER).
Who is sponsoring clinical trial NCT00336076?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia